CatalystMarker
← board

NOTV

distress 4/10 · elevated risk
$0.010%today-100% from 52w high
inotiv.com1,945 employeesFounded 1974West Lafayette, INDiagnostics & Research
Revenue
$239M
Liquidity
$15M
Runway
1.4 yrs
Shares 1y
+2%

Price & events

-98.1% over 6M
$0.01$0.29$0.57Jan 26Apr 26Jul 261.1Brating: Lake Street: Buy (2026-02-10)
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-38.3%
1W
-4.7%
1M
-96.3%
3M
-98.1%
6M
-99.5%
1Y
2Y
5Y
-99.7%
All

Overview

Market Cap
$387.26K
Enterprise Value
$-14.79M
Volume
0
52 Week Range
$0.01 – $2.36
Total Shares
34.89M
Float Shares
32.32M
Short %
7.86%
% Held by Insiders
8.64%
% Held by Institutions
14.00%
Beta
3.77

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 1

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 34,888,147 · 0 offerings/1y · 0 PIPEs
  • none
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

strong buy · target $ · analysts
  • 2026-02-10Lake StreetBuy
  • 2025-12-04Lake StreetBuy
  • 2025-05-08Lake StreetBuy
  • 2024-09-30Lake StreetHold → Buy

Competitors

  • none identified

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.